Become a student member today for free and be part of the RACGP community
Enrolments for the 2019.1 OSCE FRACGP exams closing 29 March 2019
Practice Experience Program is a self-directed education program designed to support non vocationally registered doctors on their pathway to RACGP Fellowship
RACGP offer courses and events to further develop the knowledge you need to develop your GP career
Discover a world of educational opportunities to support your lifelong learning
Become a provider with the QI&CPD Program and be recognised for the quality education and training you offer GPs
The Red Book provides the general practice team with guidance on opportunistic and proactive preventive care
Send a request for information, a loan, literature search, journal article, book chapter and one-on-one remote training sessions
Download the Standards for general practice (5th edition) - a benchmark for quality care and risk management in Australian general practices
Compliance arrangements for Medicare changed on 1 July 2018
Review the requirements for collecting patient feedback
Advice and guidelines for GPs and practice teams to help protect general practice information systems
Video consultations can provide convenient and accessible healthcare delivery
Read all of the RACGP reports and submissions on various healthcare topics
Read all of the RACGP position statements on various healthcare topics
shareGP is an online space for our 39,000 RACGP members to connect with one another
Smoking status should be assessed for every patient aged 10 years and older.45 It is important to ask at every opportunity, especially if there is a related medical problem (eg. respiratory disease or CVD). Smoking status should be documented in the medical record.
The related health effects and the substantial cost are two key factors that trigger smokers to consider quitting. The Quit Now website’s online calculator, available at, can be used to estimate the cost of smoking and may be helpful to use with your patient.
Level of evidence and strength of recommendation46
When should I start screening?
All people aged 10 or older.
When should I stop screening?
No upper age limit for screening has been reported.
How often should I screen?
Take every opportunity to ask about smoking cigarettes, pipes or cigars.
Which groups are at higher risk of developing smoking-related complications and would benefit most from quitting?
What methods should I use when screening?
How should I assess readiness to quit?
This must be done in a non-judgmental and non-threatening way. For example, ‘How do you feel about your smoking?’, ‘Are you ready to quit?’.
What are the benefits and risks of preventive actions?
Quitting smoking has benefits in reducing the risk of cancers, coronary artery disease, chronic obstructive pulmonary disease and stroke. There are no risks from preventive actions.
Nicotine dependence can be assessed by asking questions related to:46
Smoking within 30 minutes of waking, smoking more than 10 cigarettes per day and history of withdrawal symptoms in previous quit attempts are all markers of nicotine dependence.
According to the RACGP’s Red book, pharmacotherapy for dependent smokers is proven to double the chances of successfully quitting.
Patients who smoke, regardless of the amount, should be offered brief advice to stop smoking.49 Smoking cessation is well established as an effective intervention within the primary care setting. Simple, single-consultation advice from a physician results in 1–3% of smokers quitting and not relapsing for one year.50
This means the number needed to treat to prevent one excess death is 67 for minimal brief advice and 22 for optimal treatment (based on conservative assumptions that only 3% of people quit on their own, 6% quit with minimal treatment, 12% quit with optimal treatment and all quit after the age of 50).51
Is counselling from a doctor effective in getting people to quit?
Yes. Brief advice given by GPs and their practice team during a single routine consultation is more effective than no intervention at all. Interventions work best for people who are ready and motivated to quit and for whom follow-up support is provided.
Who should be offered patient education?
All patients, especially those presenting with smoking-related problems.52 This should be supplemented by written patient-education material.
Who should be offered pharmaco-therapy to assist with cessation?
Pharmacotherapy may be considered in all patients smoking more than 10 cigarettes per day. In the absence of contraindications, pharmacotherapy should be offered to all motivated smokers with evidence of nicotine dependence.
Should I counsel non-smokers about passive smoking?
Yes. Although there is no evidence regarding the effectiveness of counselling, the strong evidence on the harms of passive (second-hand) smoking justifies counselling non-smokers, especially parents of babies and young children and pregnant women, to limit exposure to tobacco smoke.53,54
I–A (for pregnant women)
Should patients be offered follow-up visits?
Yes. Patients should be offered follow-up visits at one week and one month. Further follow-up should be negotiated between doctor and patient.
Patients who are not interested in quitting should be offered brief advice on the risks of smoking and encouraged to consider quitting. Patients who are interested but unsure should be offered information on smoking cessation, including what is available to support smokers attempting to quit (Quitline, pharmacotherapy if they are nicotine-dependent) and a suggestion for a follow-up visit to discuss further.
Addressing beliefs about smoking and smoking cessation can help overcome barriers to quitting (refer to Table 5).
I can quit at any time/I am not addicted.
Ask about previous quit attempts and success rates.
Use of cessation assistance is a sign of
weakness/help is not necessary.
Reframe ‘assistance’. Explain that nicotine dependence is a powerful addiction and highlight unassisted quit rate is 3–5%.
Too addicted/too hard to quit.
Ask about previous quit attempts.
Explore pharmacotherapy used and offer options (eg. combination therapy).
Too late to quit/I might not benefit so why bother?
Benefits accrue at all ages and are greater if earlier – at age 30 years, similar life expectancy to non-smoker. Provide evidence/feedback (eg. spirometry, lung age, absolute risk score).
My health has not been affected by smoking/you have to die of something/I know a heavy smoker who has lived for a long time.
Provide evidence/feedback (eg. spirometry, lung age, cardiovascular absolute risk score). Reframe (eg. chronic obstructive pulmonary disease (COPD) = smoker’s lung).
Not enough willpower/no point in trying unless you want to/to quit successfully you really have to want to, then you will just do it.
Explore motivation and confidence. Explore and encourage use of effective strategies (eg.Quitline, pharmacotherapy).
Smokers who are ready to quit should be assisted by:
Tobacco use is most effectively treated with a comprehensive approach involving behavioural support and pharmacotherapy. Nicotine replacement therapy (NRT) increases quit rates by about 60% compared to placebo.46 All forms of NRT monotherapy have similar efficacy in increasing long-term cessation compared to placebo.
Combining the nicotine patch with an oral form of NRT is more effective than monotherapy and should be offered to smokers who are unable to quit or experience cravings or withdrawal symptoms despite monotherapy. Pre-cessation treatment with a nicotine patch, usually started two weeks prior to ‘quit day’, has also been shown to improve success rates compared to starting the patch on quit day.55 There are some contraindications, including recent onset of life-threatening arrhythmias, pregnancy or lactation. Caution should also be exercised in patients with recent acute myocardial infarction or severe or worsening angina pectoris, recent stroke and arrhythmia.
Varenicline is the most effective monotherapy, more than doubling sustained abstinence rates at six months’ follow-up compared to placebo.56 Nausea occurs in about 30% of users but can be minimised by gradually up-titrating the dose and having the tablets with food. Although there have been concerns about neuropsychiatric adverse effects with varenicline, evidence from a meta-analysis shows no increase in rates of suicidal events, depression, or aggression/agitation compared to placebo.57
Bupropion, when combined with behavioural support, has been shown to be effective in patients who are dependent.58 It is contraindicated in patients with allergy to bupropion, seizures, anorexia or bulimia, central nervous system (CNS) tumours or monoamine-oxidase inhibitor (MAOI) treatment within 14 days. It should be used with caution in patients who abuse alcohol, have experienced recent head trauma, have diabetes, renal impairment, patients who use stimulants or anorectic drugs, drugs that may lower seizure threshold and patients on NRT.
Patients with other drug and alcohol problems, or who are living with mental health issues may need particular support to reduce smoking. SANE Australia has materials for GPs and people who smoke and are living with mental issues. SANE Australia can be contacted on 1800 18 SANE (7263) or online.
Motivated patients who are physically or psychologically addicted to nicotine should be referred to a quit program 46 such as Quitline, a tobacco treatment specialist or local Quit programs. Patients with a chronic medical condition and complex needs may benefit from a GP Management Plan and Team Care Arrangement under Medicare’s CDM GP services (formerly Enhanced Primary Care). Refer to Chapter 4 and Chapter 5 for more information about what is available under Medicare, including links to MBS templates.
Quitline (13 78 48) is a telephone service that offers information and advice or counselling for people who want to quit smoking. Quitline can send patients a Quit Book or provide information on:
Visit Quit Now for more information.
Reproduced with permission from the Department of Health
Refer to Chapter 5 for information on referral services and tools, such as a lung age calculator and where to locate a tobacco specialist.
Section 4.5.4 includes information on how to set up a practice directory.
Patients should be reviewed within one week, and again at one month, of stopping smoking in order to help increase the long-term chance of quitting. The practice information system should generate reminders or lists of patients who are overdue for follow-up (refer to Section 4.5.1). Most relapses occur within the first few weeks of quitting and patients should be counselled that they should not give up even if they have relapsed. It often takes a number of attempts to quit successfully. Relapse is associated with the severity of withdrawal symptoms and a number of other factors, such as stress and weight gain, so addressing these regularly will help the patient to remain tobacco-free. Strategies to deal with the habit of negative emotions also help patients to become long-term non-smokers.
Smoking, nutrition, alcohol, physical activity (SNAP) 2nd Edition (PDF 1 MB)